Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Hemispherx BioPharma Company Profile (NYSE:HEB)

Consensus Ratings for Hemispherx BioPharma (NYSE:HEB) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Hemispherx BioPharma (NYSE:HEB)
Show:
DateFirmActionRatingPrice TargetDetailsShare
1/21/2014Chardan CapitalInitiated CoverageBuy$3.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 2/28/2013 forward)